Search results
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers
Investopedia· 2 days agoGeron (GERN) shares skyrocketed over 19% in intraday trading Friday after the Food and Drug...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via Yahoo Finance· 2 days agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters via Yahoo News· 2 days agoFood and Drug Administration for its blood disorder drug. The health regulator's nod...anemia in...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 4 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
FDA approves Geron’s RYTELO for MDS associated anaemia
Pharmaceutical Technology via Yahoo Finance· 2 days ago“The approval of RYTELO as the first telomerase inhibitor is a testament to the power of our science...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 1 day ago*Stock Advisor returns as of June 3, 2024 Cory Renauer has no position in any of the stocks...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 5 days agoThis is a valuable alternative to the lengthy traditional approval process, but it comes with the...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 5 days agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
BlueSphere Bio's huge week with FDA approval for dosing and National Cancer Institute agreement -...
The Business Journals· 2 days agoBlueSphere Bio, a UPMC Enterprises spinout and Pittsburgh-based drug development company, logged a big week in its development with a clearance from the U.S. Food and < ...